Related Experiment Video

Updated: Jun 1, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Hepatitis C-related arthropathy: Diagnostic and treatment considerations

Nyingi M Kemmer1, Kenneth E Sherman

  • 1Associate professor of medicine in the department of internal medicine, division of digestive diseases, at the University of Cincinnati and is associated with the Cincinnati VA Medical Center.

The Journal of Musculoskeletal Medicine
|June 1, 2011
PubMed

Insights

Hepatitis C-related arthropathy, a common complication of hepatitis C virus (HCV) infection, can cause disabling arthritis. Early HCV diagnosis aids treatment selection and distinguishes it from rheumatoid arthritis.

Area of Science:

  • Rheumatology
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis C-related arthropathy is a frequent extrahepatic manifestation of hepatitis C virus (HCV) infection.
  • While often disabling, the prognosis for this condition is typically favorable.
  • Atypical chronic inflammatory arthritis of unknown origin warrants evaluation for HCV infection.

Purpose of the Study:

  • To highlight the significance of Hepatitis C-related arthropathy.
  • To emphasize the diagnostic utility of anti-cyclic citrullinated peptide antibodies.
  • To discuss current treatment approaches and future research directions.

Main Methods:

  • Review of clinical presentation and diagnostic markers for HCV-related arthropathy.
  • Comparison with rheumatoid arthritis using antibody testing.
  • Discussion of treatment strategies favored by liver disease specialists.

Main Results:

  • Anti-cyclic citrullinated peptide antibody testing aids in differentiating HCV-related arthropathy from rheumatoid arthritis.
  • Early identification of HCV infection is crucial for effective therapeutic management.
  • A stepwise treatment approach is commonly preferred by specialists in the absence of formal guidelines.

Conclusions:

  • HCV-related arthropathy requires consideration in patients with unexplained inflammatory arthritis.
  • Accurate diagnosis influences treatment choices and patient outcomes.
  • Further research into pathogenesis and novel therapies is essential for advancing patient care.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...